Residual Stone Volume Predicts Health Care Consumption and Stone Events: Analysis of Two-Year Results of the ASPIRE Study
High-quality volumetric analysis supports evaluation of stone removal therapies, as residual stone volume predicts HCEs and SE. SURE significantly reduces the downstream incidence and risk of HCEs compared with standard URS.
Authors
- Karen Stern (ORCID: https://orcid.org/0000-0001-7265-4220)
- Robert Medairos
- Kaitlan Cobb
- Jay Page
- Ilya Sobol
- Glenn M. Preminger (ORCID: https://orcid.org/0000-0003-4287-602X)
- Charles G. Marguet
- Mark D. White (ORCID: https://orcid.org/0000-0002-1431-0339)
- Thomas Mueller (ORCID: https://orcid.org/0000-0002-1045-2110)
- Brian R. Matlaga
- Loren Jones
- Michael Lipkin
- Thomas Chi
- Brett Johnson
- Robert Barsky
- Naren Nimmagadda
- J. Stuart Wolf
- David Cuellar
Institutions
- Prisma Health (US)
- University of Arizona (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Arizona Science Center (US)
- University of Alabama at Birmingham (US)
- Urology of Virginia (US)
- Austin Diagnostic Clinic (US)
- Summit Medical Group (United States) (US)
- Mayo Clinic Hospital (US)
- Duke University Health System (US)
- Arizona Oncology (US)
- Tucson Orthopaedic Institute (US)
- Albany Medical Center Hospital (US)
- The University of Texas at Austin (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Journal of Endourology
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1177/08927790261420565
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00